Hepatitis C Core Antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis
View ORCID ProfileMaryam Sadeghimehr, View ORCID ProfileOlivia Keiser, Francesco Negro, Maia Butsashvili, Sonjelle Shilton, Irina Tskhomelidze, Maia Tsereteli, View ORCID ProfileBarbara Bertisch, Janne Estill
doi: https://doi.org/10.1101/2019.12.12.19014621
Maryam Sadeghimehr
1Institute of Global Health, University of Geneva, Geneva, Switzerland
Olivia Keiser
1Institute of Global Health, University of Geneva, Geneva, Switzerland
Francesco Negro
2Divisions of Gastroenterology and Hepatology and of Clinical Pathology, Geneva University Hospitals, Geneva, Switzerland
Maia Butsashvili
3Clinic Neolab, Tbilisi, Georgia
Sonjelle Shilton
4FIND, Geneva, Switzerland
Irina Tskhomelidze
5TEPHINET for Georgia Hepatitis C Elimination Program, I. Javakhishvili Tbilisi State University, Tbilisi, Georgia
Maia Tsereteli
6Department of HIV/AIDS, Hepatitis, STI and TB, National Center for Disease Control and Public Health, Tbilisi, Georgia
Barbara Bertisch
1Institute of Global Health, University of Geneva, Geneva, Switzerland
7Checkin Helvetiaplatz, Zürich, Switzerland
Janne Estill
1Institute of Global Health, University of Geneva, Geneva, Switzerland
8Institute of Mathematical Statistics and Actuarial Science, University of Bern, Bern, Switzerland
Data Availability
We reviewed the literature and contacted persons directly involved in the elimination project in the country of Georgia who helped to interpret already published data.
Posted December 15, 2019.
Hepatitis C Core Antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis
Maryam Sadeghimehr, Olivia Keiser, Francesco Negro, Maia Butsashvili, Sonjelle Shilton, Irina Tskhomelidze, Maia Tsereteli, Barbara Bertisch, Janne Estill
medRxiv 2019.12.12.19014621; doi: https://doi.org/10.1101/2019.12.12.19014621
Hepatitis C Core Antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis
Maryam Sadeghimehr, Olivia Keiser, Francesco Negro, Maia Butsashvili, Sonjelle Shilton, Irina Tskhomelidze, Maia Tsereteli, Barbara Bertisch, Janne Estill
medRxiv 2019.12.12.19014621; doi: https://doi.org/10.1101/2019.12.12.19014621
Subject Area
Subject Areas
- Addiction Medicine (372)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2756)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12406)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4266)
- Geriatric Medicine (396)
- Health Economics (700)
- Health Informatics (2760)
- Health Policy (1020)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4046)
- Nursing (216)
- Nutrition (600)
- Oncology (2132)
- Ophthalmology (606)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1149)
- Primary Care Research (470)
- Public and Global Health (6659)
- Radiology and Imaging (1447)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)